Live Oak Private Wealth LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 4.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 33,268 shares of the company’s stock after selling 1,668 shares during the quarter. HCA Healthcare makes up 1.7% of Live Oak Private Wealth LLC’s portfolio, making the stock its 15th biggest position. Live Oak Private Wealth LLC’s holdings in HCA Healthcare were worth $12,971,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in HCA. BlackRock Inc. bought a new position in HCA Healthcare during the 2nd quarter worth about $5,069,974,000. Norges Bank bought a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $1,262,513,000. Legal & General Group Plc bought a new position in HCA Healthcare in the second quarter worth approximately $410,992,000. Jupiter Topco LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at $371,138,000. Finally, Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare in the 4th quarter worth $374,037,000. 62.73% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
HCA has been the topic of several analyst reports. Cantor Fitzgerald cut their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. JPMorgan Chase & Co. lowered their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Oppenheimer lowered their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $462.64.
HCA Healthcare Price Performance
NYSE HCA opened at $413.02 on Wednesday. The stock’s fifty day moving average price is $402.35 and its 200 day moving average price is $439.62. The company has a market cap of $89.42 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 1.44 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the company earned $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. Research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
